Show simple item record

dc.contributor.authorCzypionka, Thomas
dc.contributor.authorIftekhar, Emil N
dc.contributor.authorPrainsack, Barbara
dc.contributor.authorPriesemann, Viola
dc.contributor.authorBauer, Simon
dc.contributor.authorCalero Valdez, André
dc.contributor.authorCuschieri, Sarah
dc.contributor.authorGlaab, Enrico
dc.contributor.authorGrill, Eva
dc.contributor.authorKrutzinna, Jenny
dc.contributor.authorLionis, Christos
dc.contributor.authorMachado, Helena
dc.contributor.authorMartins, Carlos
dc.contributor.authorPavlakis, George N
dc.contributor.authorPerc, Matjaž
dc.contributor.authorPetelos, Elena
dc.contributor.authorPickersgill, Martyn
dc.contributor.authorSkupin, Alexander
dc.contributor.authorSchernhammer, Eva
dc.contributor.authorSzczurek, Ewa
dc.contributor.authorTsiodras, Sotirios
dc.contributor.authorWilleit, Peter
dc.contributor.authorWilmes, Paul
dc.date.accessioned2022-02-11T02:33:38Z
dc.date.available2022-02-11T02:33:38Z
dc.date.issued2022-02
dc.identifier.issn2666-7762
dc.identifier.other35005678
dc.identifier.otherPMC8720492
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/333895
dc.description.abstractIn the summer of 2021, European governments removed most NPIs after experiencing prolonged second and third waves of the COVID-19 pandemic. Most countries failed to achieve immunization rates high enough to avoid resurgence of the virus. Public health strategies for autumn and winter 2021 have ranged from countries aiming at low incidence by re-introducing NPIs to accepting high incidence levels. However, such high incidence strategies almost certainly lead to the very consequences that they seek to avoid: restrictions that harm people and economies. At high incidence, the important pandemic containment measure 'test-trace-isolate-support' becomes inefficient. At that point, the spread of SARS-CoV-2 and its numerous harmful consequences can likely only be controlled through restrictions. We argue that all European countries need to pursue a low incidence strategy in a coordinated manner. Such an endeavour can only be successful if it is built on open communication and trust.
dc.languageeng
dc.publisherElsevier BV
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourcenlmid: 101777707
dc.sourceessn: 2666-7762
dc.titleThe benefits, costs and feasibility of a low incidence COVID-19 strategy.
dc.typeArticle
dc.date.updated2022-02-11T02:33:37Z
prism.publicationNameLancet Reg Health Eur
prism.volume13
dc.identifier.doi10.17863/CAM.81311
rioxxterms.versionofrecord10.1016/j.lanepe.2021.100294
rioxxterms.versionVoR
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0/
dc.contributor.orcidCzypionka, Thomas [0000-0002-3381-1075]
dc.contributor.orcidPrainsack, Barbara [0000-0002-6335-1532]
dc.contributor.orcidGlaab, Enrico [0000-0003-3977-7469]
dc.identifier.eissn2666-7762
pubs.funder-project-idWellcome Trust (209519/Z/17/Z, 106612/Z/14/Z)
pubs.funder-project-idEconomic and Social Research Council (ES/S013873/1)
cam.issuedOnline2022-01-02


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International